Physical Activity in Persons With Charcot-Marie-Tooth: Developing a Measurement Instrument
NCT ID: NCT04461613
Last Updated: 2021-02-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2020-09-15
2021-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physical Activity, mHealth and Intellectual Disability - a Pilot Study
NCT04929106
Physical Activity Level of Norwegian Boys with Duchenne Muscular Dystrophy
NCT03947112
A PATH (Promoting Activity and Trajectories of Health) for Children
NCT03189862
Physical Activity and Fatigue in Myasthenia Gravis
NCT03905473
Activity Pacing for Fatigue Management
NCT06001970
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Apart from the physical activity in a rehabilitation center, physical activity also needs to be maintained at the community level in people's everyday life. To measure physical activity level in the community, we need an instrument that is designed for doing so. A questionnaire can be used to collect information about type of activity, activity duration and intensity. The instruments available so far to measure physical activity at the community level are not specifically adapted to persons with CMT. Therefore, this study will focus on revising the questionnaire based on the inputs from persons with CMT themselves. Furthermore, the revised questionnaire will be compared with the original one in addition to yet another instrument.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SCREENING
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
In the first week, this group will receive a physical activity diary and be required to fill it out for 7 days. After completion of the activity diary, group 1 will receive an original International Physical Activity Questionnaire short form (IPAQ-sf). Group 1 will be asked to fill it out with information about physical activities in the last 7 days.
In the second week, the group will need to fill another physical activity diary for 7 days. After the completion of this, group 1 will be asked to fill a revised version of IPAQ-sf to describe physical activities in the last 7 days.
Original IPAQ followed by a revised one.
Comparing two questionnaires (a revised version and an original International Physical Activity Questionnaire short form) with an activity diary.
Group 2
In the first week, this group will receive a physical activity diary and be required to fill it out for 7 days. After completion of the activity diary, group 2 will receive a revised version of International Physical Activity Questionnaire short form (IPAQ-sf). Group 2 will be asked to fill it out with information about physical activities in the last 7 days.
In the second week, the group will need to fill another physical activity diary for 7 days. After the completion of this, group 2 will be asked to fill an original IPAQ-sf to describe physical activities in the last 7 days.
Revised IPAQ followed by an original one.
Comparing two questionnaires (a revised version and an original International Physical Activity Questionnaire short form) with an activity diary.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Original IPAQ followed by a revised one.
Comparing two questionnaires (a revised version and an original International Physical Activity Questionnaire short form) with an activity diary.
Revised IPAQ followed by an original one.
Comparing two questionnaires (a revised version and an original International Physical Activity Questionnaire short form) with an activity diary.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Residing in Norway
* Age between 18 to 65 years old.
Exclusion Criteria
* Experiencing serious illness (e.g. bedridden, hospitalized).
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Norwegian National Advisory Unit on Rare Disorders (NKSD)
UNKNOWN
University of Oslo
OTHER
Foreningen for Muskelsyke
UNKNOWN
Oslo University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kristin Ørstavik
Consultant in Neurology and Head of Section for Rare Neuromuscular disorders including EMAN, Department of Neurology, Oslo University Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kristin Ørstavik, MD, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Oslo University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oslo University Hospital
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020/94587
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.